Search clinical trials for: COA566
Total 2 results
-
Novartis PharmaceuticalsMedicines for Malaria VentureCompletedAcute Uncomplicated Falciparum MalariaBurkina Faso, Benin, Congo, Nigeria, Togo
-
NovartisCompleted
Sponsors and Collaborators
- Fundación Pública Andaluza Progreso y Salud
- Edanz Group Japan Ltd
- Frankel, Amylynne, M.D.
- Pharmaspecific
- Laboratorios Viñas, S.A.
- King Baudouin Foundation
- Korrus Inc.
- Ruba Musharbash Nutrition Consultancy Center
- Manmohan Cardiothoracic Vascular and Transplant Center
- Gulsah Ilhan
- Walgreens Co.
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Michael J. Wesley, PhD
- HeartPoint Global
- Center for Rare Neurological Diseases, Norcross, GA
- Army Hospital, Percy
- Ana Paula Costella
- IRCCS Don Gnocchi, Milano, Italy
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- View Full List
Medical Conditions
- Menopause
- Coagulation Disorder Neonatal
- Gastroenteritis Rotavirus
- Brain Arteriovenous Malformation
- Paralysis of Vocal Cords or Larynx
- Localized Unresectable Adult Primary Liver Cancer
- Pelvis Tumors
- Impairment, Coordination
- Severe Atopic Dermatitis
- Cognitive Function, Social 1
- Facial Involvement
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Malignant Intracranial Germ Cell Tumor
- Ankylosed Teeth
- Developmental Language Disorder and Language Impairment
- Lung Neuroendocrine Tumor
- Uncontrolled Type 2 Diabetes Mellitus
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Cardiovascular Outcomes
- Kidney Damage
- View Full List
Drug Interventions
- FHND5071
- LDEPA
- CD25 treatment
- Miglustat
- Thiotepa
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- Rituximab plus CHOP
- Apremilast
- Interleukin-2
- Transdermal estradiol
- Insulin
- Extended release guanfacine
- Dexmedetomidine
- Ozanimod
- 5-Fluorouracil
- Methotrexate
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- Exendin 9-39
- Interferon beta-1b (Betaferon, BAY86-5046)
- Lidocaine/ ketamine
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Australia
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Iran
- Contract Research Organizations in Italy
- Contract Research Organizations in Liberia
- Contract Research Organizations in Mexico
- Contract Research Organizations in Qatar
- Contract Research Organizations in Singapore
- Contract Research Organizations in Taiwan
- CRO list by country